Which hospitals have Sacituzumab govitecan?

Sacituzumab govitecan (Sacituzumab govitecan) is a conjugate ofTrop-2-directed antibody and a topoisomerase inhibitor. Currently it is only available as an intravenous infusion and should not be administered as an intravenous bolus or push injection. GosatuzumabThe original drug has been launched in China, but it has not yet been included in the medical insurance. SpecificationsThe price of each 100 mg bottle may be around 10,000 yuan, which is relatively expensive. This drug may be sold in domestic hospitals and other places, but it is a strictly controlled drug and its purchase is difficult. The original gosatuzumab drug marketed overseas has three versions: European version, American version, and Singapore version. SpecificationsThe price of each 100mg bottle may be around RMB 10,000-35,000 (the price may fluctuate due to exchange rates).